Gene · 3020
Papers2,385
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,385
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retrograde longitudinal imaging analyses of IDH-wildtype glioblastoma reveal its clinical timeline from radiological birth to death. | Neurooncol Adv | 2026 | 41732237 | PubTator, text mining | PubMed |
| Molecular features in gangliogliomas: a systematic review. | Childs Nerv Syst | 2026 | 41721014 | PubTator, text mining | PubMed |
| Use of tumor treating fields for a malignant brain tumor in a pregnant woman: Case report. | Brain Spine | 2026 | 41716879 | PubTator, text mining | PubMed |
| Primary subdural tumor mimicking subdural hematoma: illustrative case. | J Neurosurg Case Lessons | 2026 | 41628438 | PubTator, text mining | PubMed |
| A recently evolved domain of the human ING1 epigenetic regulator targets mitochondria and induces senescence. | Cell Mol Life Sci | 2026 | 41617915 | PubTator, text mining | PubMed |
| Adult-Onset Diffuse Midline Glioma, H3K27-Altered: A Genomics-Guided, Individualized, Multimodal Treatment Approach. | Brain Sci | 2026 | 41594818 | PubTator, text mining | PubMed |
| Epigenetic mechanisms and therapeutic advances in diffuse midline glioma (Review). | Oncol Rep | 2026 | 41574724 | PubTator, text mining | PubMed |
Single-Cell RNA Sequencing Revealing Dysregulated Perturbations of Tregs in Psoriasis and Construction of a Treg-Related Diagnostic Model via a 101- Combination Machine Learning Computational Framework | Endocr Metab Immune Disord Drug Targets | 2026 | 41572692 | PubTator, text mining | PubMed |
| <p>CDK1 depletion suppresses glioma malignancy through cell cycle pathway regulation: Mechanistic insights from functional and molecular profiling</p>. | Oncol Rep | 2026 | 41543195 | PubTator, text mining | PubMed |
| Aneurysmal Bone Cyst-cloaked Codman's Tumor in the Patella: Case Report of an Easily Misdiagnosed Entity. | J Orthop Case Rep | 2026 | 41541431 | PubTator, text mining | PubMed |
| Preclinical assessment of checkpoint blockade combined with DNA methyltransferase inhibition in high-risk pediatric brain tumors reveals limited therapeutic synergy. | Neurooncol Adv | 2026 | 41541220 | PubTator, text mining | PubMed |
| Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma. | Commun Biol | 2026 | 41540212 | PubTator, text mining | PubMed |
| H3-3A gene mutation analysis in giant cell tumor of bone and its histologic mimics: A single institutional study from India. | Ann Diagn Pathol | 2026 | 41539257 | PubTator, text mining | PubMed |
| Clinical Significance of Molecular Genetic Analysis in Diffuse Intrinsic Pontine Glioma: Two Case Reports. | Pediatr Blood Cancer | 2026 | 41449987 | PubTator, text mining | PubMed |
| H3.3G34W immunohistochemistry negative giant cell tumour of bone. Extended analysis of 35 such cases from a single institution in India. | Virchows Arch | 2026 | 41196370 | PubTator, text mining | PubMed |
| Diffuse hemispheric glioma, H3 G34-mutant, a single centre experience and histopathological analysis. | Virchows Arch | 2026 | 41057664 | PubTator, text mining | PubMed |
| Expanding the spectrum of AFF2 carcinoma: clinical, morphological, immunohistochemical, and molecular characteristics of five cases harboring alternate fusions. | Virchows Arch | 2026 | 40494991 | PubTator, text mining | PubMed |
| Immunohistochemical and molecular profiling of uveal melanoma: clinicopathological correlations from an Italian cohort. | Pathologica | 2025 | 41954344 | PubTator, text mining | PubMed |
| Soft tissue recurrence in giant cell tumor of bone: Risk factors and radiological and histopathological features. | Acta Orthop Traumatol Turc | 2025 | 41578816 | PubTator, text mining | PubMed |
| Malignant and metastatic giant cell tumors of bone; clinical course of primary or secondary malignant and pulmonary metastatic variants. | J Bone Oncol | 2025 | 41399766 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3020/papers?page=3